These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


473 related items for PubMed ID: 22157469

  • 1. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone.
    Rosen CF, Mussani F, Chandran V, Eder L, Thavaneswaran A, Gladman DD.
    Rheumatology (Oxford); 2012 Mar; 51(3):571-6. PubMed ID: 22157469
    [Abstract] [Full Text] [Related]

  • 2. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis.
    Husted JA, Gladman DD, Farewell VT, Cook RJ.
    Arthritis Rheum; 2001 Apr; 45(2):151-8. PubMed ID: 11324779
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens.
    Gniadecki R, Robertson D, Molta CT, Freundlich B, Pedersen R, Li W, Boggs R, Zbrozek AS.
    J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1436-43. PubMed ID: 22035157
    [Abstract] [Full Text] [Related]

  • 5. Essential factors influencing health-related-quality of life in psoriasis.
    Rønneberg Mehren C, Clemmensen A, Boe-Hansen Dall A, Philipsen P, Gniadecki R.
    J Drugs Dermatol; 2014 Mar; 13(3):246-50. PubMed ID: 24595566
    [Abstract] [Full Text] [Related]

  • 6. Willingness-to-pay and quality of life in patients with vitiligo.
    Radtke MA, Schäfer I, Gajur A, Langenbruch A, Augustin M.
    Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
    [Abstract] [Full Text] [Related]

  • 7. Sleep Disturbance in Psoriatic Disease: Prevalence and Associated Factors.
    Wong ITY, Chandran V, Li S, Gladman DD.
    J Rheumatol; 2017 Sep; 44(9):1369-1374. PubMed ID: 28620064
    [Abstract] [Full Text] [Related]

  • 8. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis.
    Reich K, Krüger K, Mössner R, Augustin M.
    Br J Dermatol; 2009 May; 160(5):1040-7. PubMed ID: 19210498
    [Abstract] [Full Text] [Related]

  • 9. Health-related quality of life in psoriasis: an analysis of Psocare project patients.
    Spandonaro F, Altomare G, Berardesca E, Calzavara-Pinton P, Chimenti S, Girolomoni G, Peserico A, Guerra AP, Vena GA, Polistena B, Ayala F.
    G Ital Dermatol Venereol; 2011 Jun; 146(3):169-77. PubMed ID: 21566546
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative.
    Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, Maccarone M, Carton L, Otsa K, Sooäär I, Heiberg T, Bertheussen H, Cañete JD, Sánchez Lombarte A, Balanescu A, Dinte A, de Vlam K, Smolen JS, Stamm T, Niedermayer D, Békés G, Veale D, Helliwell P, Parkinson A, Luger T, Kvien TK, EULAR PsAID Taskforce.
    Ann Rheum Dis; 2014 Jun; 73(6):1012-9. PubMed ID: 24790067
    [Abstract] [Full Text] [Related]

  • 13. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
    Hu SW, Holt EW, Husni ME, Qureshi AA.
    Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
    [Abstract] [Full Text] [Related]

  • 14. Depression and anxiety in psoriatic disease: prevalence and associated factors.
    McDonough E, Ayearst R, Eder L, Chandran V, Rosen CF, Thavaneswaran A, Gladman DD.
    J Rheumatol; 2014 May; 41(5):887-96. PubMed ID: 24692521
    [Abstract] [Full Text] [Related]

  • 15. Disease burden and quality of life in psoriasis patients with and without comorbid psoriatic arthritis: results from National Psoriasis Foundation panel surveys.
    Edson-Heredia E, Zhu B, Guo J, Maeda-Chubachi T, Lebwohl M.
    Cutis; 2015 Mar; 95(3):173-8. PubMed ID: 25844782
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Quantifying harmful effects of psoriatic diseases on quality of life: Cardio-metabolic outcomes in psoriatic arthritis study (COMPASS).
    Dalal DS, Lin YC, Brennan DM, Borkar N, Korman N, Husni ME.
    Semin Arthritis Rheum; 2015 Jun; 44(6):641-5. PubMed ID: 26058346
    [Abstract] [Full Text] [Related]

  • 18. Is the health-related quality of life and functional status of patients with psoriatic arthritis worse than that of patients with psoriasis alone?
    Tezel N, Yilmaz Tasdelen O, Bodur H, Gul U, Kulcu Cakmak S, Oguz ID, Karabulut E.
    Int J Rheum Dis; 2015 Jan; 18(1):63-9. PubMed ID: 24460852
    [Abstract] [Full Text] [Related]

  • 19. Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life.
    Katugampola RP, Hongbo Y, Finlay AY.
    Br J Dermatol; 2005 Jun; 152(6):1256-62. PubMed ID: 15948990
    [Abstract] [Full Text] [Related]

  • 20. Disease characteristics in patients with and without psoriatic arthritis treated with etanercept.
    Papp K, Poulin Y, Vieira A, Shelton J, Poulin-Costello M.
    J Eur Acad Dermatol Venereol; 2014 May; 28(5):581-9. PubMed ID: 23465037
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.